DK1007034T3 - Præparater indeholdende Bergamottin til forøgelse af den orale biotilgængelighed af farmaceutiske midler - Google Patents

Præparater indeholdende Bergamottin til forøgelse af den orale biotilgængelighed af farmaceutiske midler

Info

Publication number
DK1007034T3
DK1007034T3 DK98939311T DK98939311T DK1007034T3 DK 1007034 T3 DK1007034 T3 DK 1007034T3 DK 98939311 T DK98939311 T DK 98939311T DK 98939311 T DK98939311 T DK 98939311T DK 1007034 T3 DK1007034 T3 DK 1007034T3
Authority
DK
Denmark
Prior art keywords
bergamottin
oral bioavailability
increasing
pharmaceutical agents
preparations containing
Prior art date
Application number
DK98939311T
Other languages
Danish (da)
English (en)
Inventor
Kan He
Paul Hollenberg
Thomas F Woolf
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK1007034T3 publication Critical patent/DK1007034T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK98939311T 1997-08-19 1998-08-11 Præparater indeholdende Bergamottin til forøgelse af den orale biotilgængelighed af farmaceutiske midler DK1007034T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5612997P 1997-08-19 1997-08-19
PCT/US1998/016579 WO1999008676A1 (en) 1997-08-19 1998-08-11 Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents

Publications (1)

Publication Number Publication Date
DK1007034T3 true DK1007034T3 (da) 2004-03-22

Family

ID=22002350

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98939311T DK1007034T3 (da) 1997-08-19 1998-08-11 Præparater indeholdende Bergamottin til forøgelse af den orale biotilgængelighed af farmaceutiske midler

Country Status (15)

Country Link
US (1) US6509371B1 (xx)
EP (1) EP1007034B1 (xx)
JP (1) JP2001515035A (xx)
KR (1) KR100510809B1 (xx)
AT (1) ATE253357T1 (xx)
AU (1) AU747051B2 (xx)
BR (1) BR9812131A (xx)
CA (1) CA2291233C (xx)
DE (1) DE69819519T2 (xx)
DK (1) DK1007034T3 (xx)
ES (1) ES2209184T3 (xx)
NZ (1) NZ502668A (xx)
PT (1) PT1007034E (xx)
WO (1) WO1999008676A1 (xx)
ZA (1) ZA987436B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1014575A3 (fr) * 2002-01-16 2004-01-13 Chapelle Andre Composition a base de 5,7 dmc et/ou de bergamottine.
US7169763B2 (en) * 2002-02-22 2007-01-30 Oliver Yoa-Pu Hu Cytochrome P450 3A inhibitors and enhancers
EP1847266B1 (en) 2005-01-21 2013-12-25 ARKRAY, Inc. Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same
JP4902964B2 (ja) * 2005-03-30 2012-03-21 株式会社ファンケル 薬物の代謝阻害剤とその使用
EP3003288A1 (en) 2013-05-30 2016-04-13 Nanobiotix Pharmaceutical composition, preparation and uses thereof
WO2016083338A1 (en) * 2014-11-25 2016-06-02 Nanobiotix Pharmaceutical compositions, preparation and uses thereof
FI3229776T3 (fi) 2014-11-25 2023-08-15 Curadigm Sas Farmaseuttinen koostumus, joka yhdistää ainakin kaksi erillistä nanopartikkelia ja farmaseuttisen yhdisteen, sen valmistus ja käytöt
KR101729494B1 (ko) 2015-06-29 2017-04-25 제주대학교 산학협력단 6,7-디하이드록시 베르가모틴을 함유한 화장료 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2996838B2 (ja) * 1993-07-12 2000-01-11 株式会社ポッカコーポレーション 抗菌剤
US5567592A (en) 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
US5716928A (en) 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US5665386A (en) 1995-06-07 1997-09-09 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US5916566A (en) * 1995-06-07 1999-06-29 Avmax, Inc. Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds
US6160006A (en) * 1996-10-18 2000-12-12 Wayne State University 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor in grapefruit

Also Published As

Publication number Publication date
BR9812131A (pt) 2000-07-18
WO1999008676A1 (en) 1999-02-25
AU8777098A (en) 1999-03-08
US6509371B1 (en) 2003-01-21
DE69819519T2 (de) 2004-09-23
NZ502668A (en) 2001-10-26
EP1007034B1 (en) 2003-11-05
PT1007034E (pt) 2004-03-31
KR100510809B1 (ko) 2005-08-31
ZA987436B (en) 1999-02-22
EP1007034A1 (en) 2000-06-14
KR20010023034A (ko) 2001-03-26
DE69819519D1 (de) 2003-12-11
ATE253357T1 (de) 2003-11-15
CA2291233A1 (en) 1999-02-25
JP2001515035A (ja) 2001-09-18
ES2209184T3 (es) 2004-06-16
AU747051B2 (en) 2002-05-09
CA2291233C (en) 2006-10-10

Similar Documents

Publication Publication Date Title
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
SE0001899D0 (sv) New compounds
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
AU2002231544A1 (en) Therapeutic uses of herbal compositions
YU49202A (sh) Benzazolski derivati i njihova upotreba kao modulatora jnk
BR0015188A (pt) Composições farmacêuticas
NO20062513L (no) Sammensetninger og doseringsformer for forsterket absorpsjon av metformin
GEP20053602B (en) Aripiprazole for Oral Administration
BR0108564A (pt) Preparações cosméticas contendo extratos vegetais
RS44204A (xx) Inhibitori 11-beta- hidroksistereoidne dehidrogenaze tipa 1
DK1007034T3 (da) Præparater indeholdende Bergamottin til forøgelse af den orale biotilgængelighed af farmaceutiske midler
TNSN00145A1 (fr) Derives de streptogramines, leur preparation et les compositions qui les contiennent
IL146284A0 (en) Androgen glycosides and pharmaceutical compositions containing the same
RS44304A (xx) Inhibitori 11-beta- hidroksistereoidne dehidrogenaze tipa 1
SE9604193D0 (sv) Therapeutic and cosmetic compositions, their use and method for the preparation thereof
SE9800905L (sv) Ny terapi vid glomerulonefrit
NZ512525A (en) Skin whitening compositions for oral administration comprising a solvent extract from the plant of the genus Rosaceae Pyracantha
DK1208078T3 (da) Ikke-hygroskopiske salte af aktive bestanddele der har terapeutiske og/eller ernæringsmæssige aktiveteter og sammensætninger til oral indgivelse der indeholder disse
DE60112578D1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
ATE334982T1 (de) 7-chlor-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-
AU2002236587A1 (en) Compositions for adhesion prevention
IL150979A0 (en) 9-alkylamino-1-nitroacridine derivatives
EP0955054A4 (en) AIDS CURE
EP1595879A3 (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same